FDA Inspection 1059272 — Diamond Institute for Infertility and Menopause

Diamond Institute for Infertility and Menopause — FEI 3003945103

The FDA completed an inspection of Diamond Institute for Infertility and Menopause on July 6, 2018 in Millburn, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 6, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Millburn, NJ (United States)